合計 50 件の最近のインサイダー取引記録が記録されています PDS Biotechnology Corporation (PDSB), 内訳は 47 件の買い および 0 件の売り. インサイダー買い総額は $9.26M インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Brawley Otis W, Glover Stephen C., Boesgaard Lars. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — PDSB
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-01-12 |
Brawley Otis W |
Director |
RSU 付与（制限付株式） |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Glover Stephen C. |
Director |
RSU 付与（制限付株式） |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Boesgaard Lars |
Chief Financial Officer |
RSU 付与（制限付株式） |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Freitag Gregory Gene |
Director |
RSU 付与（制限付株式） |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Ali-jackson Kamil |
Director |
RSU 付与（制限付株式） |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Toutain Stephan |
Chief Operating Officer |
RSU 付与（制限付株式） |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Conn Gregory |
Chief Scientific Officer |
RSU 付与（制限付株式） |
150,000 |
$0.98 |
$147K |
150,000 |
| 2026-01-12 |
Bedu-addo Frank |
President/ceo |
RSU 付与（制限付株式） |
548,782 |
$0.98 |
$537.81K |
548,782 |
| 2026-01-12 |
Iliev Ilian |
Director |
RSU 付与（制限付株式） |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU 付与（制限付株式） |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Shepard Kirk V. |
Chief Medical Officer |
RSU 付与（制限付株式） |
300,000 |
$0.98 |
$294K |
300,000 |
| 2025-06-12 |
Boesgaard Lars |
Chief Financial Officer |
RSU 付与（制限付株式） |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Toutain Stephan |
Chief Operations Officer |
RSU 付与（制限付株式） |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Conn Gregory |
Chief Scientific Officer |
RSU 付与（制限付株式） |
40,000 |
$1.79 |
$71.6K |
40,000 |
| 2025-06-12 |
Bedu-addo Frank |
President/ceo |
RSU 付与（制限付株式） |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU 付与（制限付株式） |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Shepard Kirk V. |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-11 |
Brawley Otis W |
Director |
RSU 付与（制限付株式） |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Glover Stephen C. |
Director |
RSU 付与（制限付株式） |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Freitag Gregory Gene |
Director |
RSU 付与（制限付株式） |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Ali-jackson Kamil |
Director |
RSU 付与（制限付株式） |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Iliev Ilian |
Director |
RSU 付与（制限付株式） |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-02-28 |
Glover Stephen C. |
Director |
情報に基づく買い |
15,061 |
$1.53 |
$23.04K |
15,061 |
| 2025-02-28 |
Freitag Gregory Gene |
Director |
情報に基づく買い |
15,060 |
$1.53 |
$23.04K |
15,060 |
| 2024-06-24 |
Brawley Otis W |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Glover Stephen C. |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Sykes Richard |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Freitag Gregory Gene |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Ali-jackson Kamil |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Iliev Ilian |
Director |
RSU 付与（制限付株式） |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-05-01 |
Toutain Stephan |
Officer |
不明 |
- |
- |
- |
- |
| 2024-05-01 |
Toutain Stephan |
Chief Operations Officer |
RSU 付与（制限付株式） |
200,000 |
$3.61 |
$722K |
200,000 |
| 2024-02-28 |
Conn Gregory |
Chief Scientific Officer |
RSU 付与（制限付株式） |
46,648 |
$5.87 |
$273.82K |
46,648 |
| 2024-02-28 |
Bedu-addo Frank |
President/ceo |
RSU 付与（制限付株式） |
300,000 |
$5.87 |
$1.76M |
300,000 |
| 2024-02-28 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU 付与（制限付株式） |
56,000 |
$5.87 |
$328.72K |
56,000 |
| 2024-01-22 |
Shepard Kirk V. |
Officer |
不明 |
- |
- |
- |
- |
| 2024-01-22 |
Shepard Kirk V. |
Chief Medical Officer |
RSU 付与（制限付株式） |
200,000 |
$4.49 |
$898K |
200,000 |
| 2023-12-04 |
Boesgaard Lars |
Officer |
不明 |
- |
- |
- |
- |
| 2023-12-04 |
Boesgaard Lars |
Chief Financial Officer |
RSU 付与（制限付株式） |
200,000 |
$5.28 |
$1.06M |
200,000 |
| 2023-07-14 |
Brawley Otis W |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Glover Stephen C. |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Sykes Richard |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Freitag Gregory Gene |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Ali-jackson Kamil |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Iliev Ilian |
Director |
RSU 付与（制限付株式） |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-01-05 |
Hill Matthew C |
Chief Financial Officer |
RSU 付与（制限付株式） |
161,200 |
- |
- |
161,200 |
| 2023-01-05 |
Wood Lauren |
Chief Medical Officer |
RSU 付与（制限付株式） |
110,800 |
- |
- |
110,800 |
| 2023-01-05 |
Conn Gregory |
Chief Scientific Officer |
RSU 付与（制限付株式） |
137,200 |
- |
- |
137,200 |
| 2023-01-05 |
Bedu-addo Frank |
President/ceo |
RSU 付与（制限付株式） |
385,300 |
- |
- |
385,300 |
| 2023-01-05 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU 付与（制限付株式） |
20,400 |
- |
- |
20,400 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
